‘Drug Discovery’
Targeting EZH2 in Cancer: AI-Driven Pipeline for Drug Discov-ery and Optimization
This study introduces an AI-driven approach that predicts and optimizes EZH2 inhibitors by carefully selecting biologically relevant features, significantly improving the efficiency and accuracy of discovering cancer treatments.
Posted by buchanle on Wednesday, June 25th, 2025 in May 2025, Bioinformatics, Drug Discovery, Epigenetics, EZH2, Machine learning